The highly anticipated annual meeting of the Radiological Society of North America (RSNA) did not disappoint this year. Attendees and exhibitors alike discovered “Tomorrow’s Radiology Today” with a wide variety of interactive booths and presentations from November 25-30 at McCormick Place in Chicago.
Here are some key themes heard on the tradeshow floor and discussed at the HealthMyne booth at this year’s meeting:
Embracing New Technology and a Better Future for Patient Care
At the Opening Session of RSNA on Sunday morning, RSNA President Vijay M. Rao, MD addressed the future of radiology, calling for a rebranding of reading rooms into digital diagnostic data hubs. Embracing the growth in digital imaging, reading rooms should be placed where clinical teams can gather, or even participate virtually, to make patient management decisions as a group. Radiologists should be creating diagnostic data hubs allowing them to work collaboratively and avoid missing important information that may slip through the cracks in isolation.
Similar sentiments were echoed by Michael P. Recht, MD, chair of the Department of Radiology at NYU Langone Health in New York City, who also spoke on Sunday regarding the future of radiology. He indicated that future developments will allow radiologists to become the center of the clinical team, using new technology to compile data that will provide previously unachievable insights.
Discovering How Radiomics Can Guide Treatment Decisions
Another widely discussed topic regarding the future of radiology was radiomics. Dr. Robert Gillies of Moffitt Cancer Center, often called the father of radiomics, spoke on Monday at the HealthMyne booth. He shared how data can be extracted from images to be used to increase precision diagnoses, assessment of prognosis, and prediction of therapy response.
An example presented at the conference was a recent study that followed a group of patients for up to six years and reported that 10 radiomic features were significantly associated with disease-free survival. Researchers concluded that radiomics can be used to identify potential biomarkers to predict prognosis of early stage solid lung adenocarcinoma patients after surgery, but further study is needed to understand how the model can guide treatment decisions for patients at high risk of disease progression.
The HealthMyne Platform is unique in that it derives radiomic features in the standard clinical workflow. A planned feature for the next release of the software due in February will allow users to create their own CDS rules based on radiomic data. This will allow them to be notified when a lesion matches a radiomic signature they are interested in.
Cancer Screening and Tumor Conference Modules Were Hot Topics at the HealthMyne Booth
As radiologists position themselves as an increasingly important part of the clinical team, they are looking for better workflows to streamline the lengthy activities involved in preparing for Tumor Conference and managing cancer screenings. Many who visited the HealthMyne booth were interested to learn how the latest modules in the HealthMyne Platform are able to help with better communication, streamlined management, and in-depth reporting for these very essential practices.
Missed our live demoes at RSNA, or interested to see these solutions in action? Click here to request a customized demo.